Serveur d'exploration MERS

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Activation of Membrane Estrogen Receptors Attenuates NOP-Mediated Tactile Antihypersensitivity in a Rodent Model of Neuropathic Pain.

Identifieur interne : 000684 ( PubMed/Checkpoint ); précédent : 000683; suivant : 000685

Activation of Membrane Estrogen Receptors Attenuates NOP-Mediated Tactile Antihypersensitivity in a Rodent Model of Neuropathic Pain.

Auteurs : Danyeal M. Wright [États-Unis] ; Keri M. Small [États-Unis] ; Subodh Nag [États-Unis] ; Sukhbir S. Mokha [États-Unis]

Source :

RBID : pubmed:31234278

Abstract

Women manifest a higher prevalence of several chronic pain disorders compared to men. We demonstrated earlier that estrogen rapidly attenuates nociceptin/orphanin FQ (N/OFQ) peptide receptor (NOP)-mediated thermal antinociception through the activation of membrane estrogen receptors (mERs). However, the effect of mER activation on NOP-mediated attenuation of tactile hypersensitivity in a neuropathic model of pain and the underlying mechanisms remain unknown. Following spared nerve injury (SNI), male and ovariectomized (OVX) female rats were intrathecally (i.t.) injected with a selective mER agonist and nociceptin/orphanin FQ (N/OFQ), the endogenous ligand for NOP, and their effects on paw withdrawal thresholds (PWTs) were tested. In addition, spinal cord tissue was used to measure changes in phosphorylated extracellular signal regulated kinase (ERK), protein kinase A (PKA), protein kinase C (PKC), and protein kinase B (Akt) levels. SNI significantly reduced PWTs in males and OVX females, indicating tactile hypersensitivity. N/OFQ restored PWTs, indicating an antihypersensitive effect. Selective mER activation attenuated the effect of N/OFQ in an antagonist-reversible manner. SNI led to a robust increase in the phosphorylation of ERK, PKA, PKC, and Akt. However, mER activation did not further affect it. Thus, we conclude that activation of mERs rapidly abolishes NOP-mediated tactile antihypersensitivity following SNI via an ERK-, PKA-, PKC-, and Akt-independent mechanism.

DOI: 10.3390/brainsci9060147
PubMed: 31234278


Affiliations:


Links toward previous steps (curation, corpus...)


Links to Exploration step

pubmed:31234278

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Activation of Membrane Estrogen Receptors Attenuates NOP-Mediated Tactile Antihypersensitivity in a Rodent Model of Neuropathic Pain.</title>
<author>
<name sortKey="Wright, Danyeal M" sort="Wright, Danyeal M" uniqKey="Wright D" first="Danyeal M" last="Wright">Danyeal M. Wright</name>
<affiliation wicri:level="2">
<nlm:affiliation>Department of Biochemistry, Cancel Biology, Neuroscience and Pharmacology, Meharry Medical College, Nashville, TN 37208, USA. dheckard@mmc.edu.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Biochemistry, Cancel Biology, Neuroscience and Pharmacology, Meharry Medical College, Nashville, TN 37208</wicri:regionArea>
<placeName>
<region type="state">Tennessee</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Small, Keri M" sort="Small, Keri M" uniqKey="Small K" first="Keri M" last="Small">Keri M. Small</name>
<affiliation wicri:level="2">
<nlm:affiliation>Department of Biochemistry, Cancel Biology, Neuroscience and Pharmacology, Meharry Medical College, Nashville, TN 37208, USA. kerimcleansmall@gmail.com.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Biochemistry, Cancel Biology, Neuroscience and Pharmacology, Meharry Medical College, Nashville, TN 37208</wicri:regionArea>
<placeName>
<region type="state">Tennessee</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Nag, Subodh" sort="Nag, Subodh" uniqKey="Nag S" first="Subodh" last="Nag">Subodh Nag</name>
<affiliation wicri:level="2">
<nlm:affiliation>Department of Biochemistry, Cancel Biology, Neuroscience and Pharmacology, Meharry Medical College, Nashville, TN 37208, USA. snag@mmc.edu.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Biochemistry, Cancel Biology, Neuroscience and Pharmacology, Meharry Medical College, Nashville, TN 37208</wicri:regionArea>
<placeName>
<region type="state">Tennessee</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Mokha, Sukhbir S" sort="Mokha, Sukhbir S" uniqKey="Mokha S" first="Sukhbir S" last="Mokha">Sukhbir S. Mokha</name>
<affiliation wicri:level="2">
<nlm:affiliation>Department of Biochemistry, Cancel Biology, Neuroscience and Pharmacology, Meharry Medical College, Nashville, TN 37208, USA. smokha@mmc.edu.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Biochemistry, Cancel Biology, Neuroscience and Pharmacology, Meharry Medical College, Nashville, TN 37208</wicri:regionArea>
<placeName>
<region type="state">Tennessee</region>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2019">2019</date>
<idno type="RBID">pubmed:31234278</idno>
<idno type="pmid">31234278</idno>
<idno type="doi">10.3390/brainsci9060147</idno>
<idno type="wicri:Area/PubMed/Corpus">000500</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000500</idno>
<idno type="wicri:Area/PubMed/Curation">000500</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000500</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000684</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000684</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Activation of Membrane Estrogen Receptors Attenuates NOP-Mediated Tactile Antihypersensitivity in a Rodent Model of Neuropathic Pain.</title>
<author>
<name sortKey="Wright, Danyeal M" sort="Wright, Danyeal M" uniqKey="Wright D" first="Danyeal M" last="Wright">Danyeal M. Wright</name>
<affiliation wicri:level="2">
<nlm:affiliation>Department of Biochemistry, Cancel Biology, Neuroscience and Pharmacology, Meharry Medical College, Nashville, TN 37208, USA. dheckard@mmc.edu.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Biochemistry, Cancel Biology, Neuroscience and Pharmacology, Meharry Medical College, Nashville, TN 37208</wicri:regionArea>
<placeName>
<region type="state">Tennessee</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Small, Keri M" sort="Small, Keri M" uniqKey="Small K" first="Keri M" last="Small">Keri M. Small</name>
<affiliation wicri:level="2">
<nlm:affiliation>Department of Biochemistry, Cancel Biology, Neuroscience and Pharmacology, Meharry Medical College, Nashville, TN 37208, USA. kerimcleansmall@gmail.com.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Biochemistry, Cancel Biology, Neuroscience and Pharmacology, Meharry Medical College, Nashville, TN 37208</wicri:regionArea>
<placeName>
<region type="state">Tennessee</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Nag, Subodh" sort="Nag, Subodh" uniqKey="Nag S" first="Subodh" last="Nag">Subodh Nag</name>
<affiliation wicri:level="2">
<nlm:affiliation>Department of Biochemistry, Cancel Biology, Neuroscience and Pharmacology, Meharry Medical College, Nashville, TN 37208, USA. snag@mmc.edu.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Biochemistry, Cancel Biology, Neuroscience and Pharmacology, Meharry Medical College, Nashville, TN 37208</wicri:regionArea>
<placeName>
<region type="state">Tennessee</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Mokha, Sukhbir S" sort="Mokha, Sukhbir S" uniqKey="Mokha S" first="Sukhbir S" last="Mokha">Sukhbir S. Mokha</name>
<affiliation wicri:level="2">
<nlm:affiliation>Department of Biochemistry, Cancel Biology, Neuroscience and Pharmacology, Meharry Medical College, Nashville, TN 37208, USA. smokha@mmc.edu.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Biochemistry, Cancel Biology, Neuroscience and Pharmacology, Meharry Medical College, Nashville, TN 37208</wicri:regionArea>
<placeName>
<region type="state">Tennessee</region>
</placeName>
</affiliation>
</author>
</analytic>
<series>
<title level="j">Brain sciences</title>
<idno type="ISSN">2076-3425</idno>
<imprint>
<date when="2019" type="published">2019</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass></textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Women manifest a higher prevalence of several chronic pain disorders compared to men. We demonstrated earlier that estrogen rapidly attenuates nociceptin/orphanin FQ (N/OFQ) peptide receptor (NOP)-mediated thermal antinociception through the activation of membrane estrogen receptors (mERs). However, the effect of mER activation on NOP-mediated attenuation of tactile hypersensitivity in a neuropathic model of pain and the underlying mechanisms remain unknown. Following spared nerve injury (SNI), male and ovariectomized (OVX) female rats were intrathecally (i.t.) injected with a selective mER agonist and nociceptin/orphanin FQ (N/OFQ), the endogenous ligand for NOP, and their effects on paw withdrawal thresholds (PWTs) were tested. In addition, spinal cord tissue was used to measure changes in phosphorylated extracellular signal regulated kinase (ERK), protein kinase A (PKA), protein kinase C (PKC), and protein kinase B (Akt) levels. SNI significantly reduced PWTs in males and OVX females, indicating tactile hypersensitivity. N/OFQ restored PWTs, indicating an antihypersensitive effect. Selective mER activation attenuated the effect of N/OFQ in an antagonist-reversible manner. SNI led to a robust increase in the phosphorylation of ERK, PKA, PKC, and Akt. However, mER activation did not further affect it. Thus, we conclude that activation of mERs rapidly abolishes NOP-mediated tactile antihypersensitivity following SNI via an ERK-, PKA-, PKC-, and Akt-independent mechanism.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
<PMID Version="1">31234278</PMID>
<DateRevised>
<Year>2020</Year>
<Month>02</Month>
<Day>25</Day>
</DateRevised>
<Article PubModel="Electronic">
<Journal>
<ISSN IssnType="Print">2076-3425</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>9</Volume>
<Issue>6</Issue>
<PubDate>
<Year>2019</Year>
<Month>Jun</Month>
<Day>21</Day>
</PubDate>
</JournalIssue>
<Title>Brain sciences</Title>
<ISOAbbreviation>Brain Sci</ISOAbbreviation>
</Journal>
<ArticleTitle>Activation of Membrane Estrogen Receptors Attenuates NOP-Mediated Tactile Antihypersensitivity in a Rodent Model of Neuropathic Pain.</ArticleTitle>
<ELocationID EIdType="pii" ValidYN="Y">E147</ELocationID>
<ELocationID EIdType="doi" ValidYN="Y">10.3390/brainsci9060147</ELocationID>
<Abstract>
<AbstractText>Women manifest a higher prevalence of several chronic pain disorders compared to men. We demonstrated earlier that estrogen rapidly attenuates nociceptin/orphanin FQ (N/OFQ) peptide receptor (NOP)-mediated thermal antinociception through the activation of membrane estrogen receptors (mERs). However, the effect of mER activation on NOP-mediated attenuation of tactile hypersensitivity in a neuropathic model of pain and the underlying mechanisms remain unknown. Following spared nerve injury (SNI), male and ovariectomized (OVX) female rats were intrathecally (i.t.) injected with a selective mER agonist and nociceptin/orphanin FQ (N/OFQ), the endogenous ligand for NOP, and their effects on paw withdrawal thresholds (PWTs) were tested. In addition, spinal cord tissue was used to measure changes in phosphorylated extracellular signal regulated kinase (ERK), protein kinase A (PKA), protein kinase C (PKC), and protein kinase B (Akt) levels. SNI significantly reduced PWTs in males and OVX females, indicating tactile hypersensitivity. N/OFQ restored PWTs, indicating an antihypersensitive effect. Selective mER activation attenuated the effect of N/OFQ in an antagonist-reversible manner. SNI led to a robust increase in the phosphorylation of ERK, PKA, PKC, and Akt. However, mER activation did not further affect it. Thus, we conclude that activation of mERs rapidly abolishes NOP-mediated tactile antihypersensitivity following SNI via an ERK-, PKA-, PKC-, and Akt-independent mechanism.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Wright</LastName>
<ForeName>Danyeal M</ForeName>
<Initials>DM</Initials>
<Identifier Source="ORCID">0000-0002-7632-0161</Identifier>
<AffiliationInfo>
<Affiliation>Department of Biochemistry, Cancel Biology, Neuroscience and Pharmacology, Meharry Medical College, Nashville, TN 37208, USA. dheckard@mmc.edu.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Small</LastName>
<ForeName>Keri M</ForeName>
<Initials>KM</Initials>
<AffiliationInfo>
<Affiliation>Department of Biochemistry, Cancel Biology, Neuroscience and Pharmacology, Meharry Medical College, Nashville, TN 37208, USA. kerimcleansmall@gmail.com.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Nag</LastName>
<ForeName>Subodh</ForeName>
<Initials>S</Initials>
<Identifier Source="ORCID">0000-0001-8834-4278</Identifier>
<AffiliationInfo>
<Affiliation>Department of Biochemistry, Cancel Biology, Neuroscience and Pharmacology, Meharry Medical College, Nashville, TN 37208, USA. snag@mmc.edu.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Mokha</LastName>
<ForeName>Sukhbir S</ForeName>
<Initials>SS</Initials>
<AffiliationInfo>
<Affiliation>Department of Biochemistry, Cancel Biology, Neuroscience and Pharmacology, Meharry Medical College, Nashville, TN 37208, USA. smokha@mmc.edu.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>SC1NS078778</GrantID>
<Agency>National Institutes of Health</Agency>
<Country></Country>
</Grant>
<Grant>
<GrantID>R25 GM59994</GrantID>
<Agency>National Institutes of Health</Agency>
<Country></Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2019</Year>
<Month>06</Month>
<Day>21</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Switzerland</Country>
<MedlineTA>Brain Sci</MedlineTA>
<NlmUniqueID>101598646</NlmUniqueID>
<ISSNLinking>2076-3425</ISSNLinking>
</MedlineJournalInfo>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">analgesia</Keyword>
<Keyword MajorTopicYN="N">neuropathic pain</Keyword>
<Keyword MajorTopicYN="N">nociceptin/orphanin FQ receptor</Keyword>
<Keyword MajorTopicYN="N">spared nerve injury</Keyword>
<Keyword MajorTopicYN="N">spinal cord</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="received">
<Year>2019</Year>
<Month>05</Month>
<Day>31</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised">
<Year>2019</Year>
<Month>06</Month>
<Day>16</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted">
<Year>2019</Year>
<Month>06</Month>
<Day>19</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2019</Year>
<Month>6</Month>
<Day>26</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2019</Year>
<Month>6</Month>
<Day>27</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2019</Year>
<Month>6</Month>
<Day>27</Day>
<Hour>6</Hour>
<Minute>1</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>epublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">31234278</ArticleId>
<ArticleId IdType="pii">brainsci9060147</ArticleId>
<ArticleId IdType="doi">10.3390/brainsci9060147</ArticleId>
<ArticleId IdType="pmc">PMC6628583</ArticleId>
</ArticleIdList>
<ReferenceList>
<Reference>
<Citation>Behav Brain Sci. 1997 Sep;20(3):371-80; discussion 435-513</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10097000</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Steroids. 1999 Jan-Feb;64(1-2):64-75</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10323674</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Endocrinology. 1999 Nov;140(11):5455-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10537181</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Neurosci Res. 2000 May 1;60(3):321-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10797534</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Brain Res. 2000 Jun 9;867(1-2):200-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10837814</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Comp Neurol. 2000 Aug 28;424(3):489-508</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10906715</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Pain. 2000 Aug;87(2):149-58</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10924808</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Mol Endocrinol. 2000 Oct;14(10):1649-60</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11043579</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Endocrinology. 2001 Jun;142(6):2336-42</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11356680</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Mol Endocrinol. 2002 Jan;16(1):70-84</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11773440</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Steroid Biochem Mol Biol. 2002 Dec;83(1-5):187-93</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12650715</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Neuroscience. 2003;118(3):769-78</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12710984</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Neurosci. 2003 Oct 22;23(29):9529-40</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">14573532</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Glia. 2004 Jan 1;45(1):89-95</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">14648549</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Biol Chem. 1951 Nov;193(1):265-75</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">14907713</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Ann N Y Acad Sci. 2003 Dec;1007:6-16</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">14993035</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Eur J Neurosci. 2004 Feb;19(4):871-83</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15009134</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Pain. 2004 Jul;110(1-2):236-45</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15275773</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Endocrinology. 2005 Feb;146(2):624-32</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15539556</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Science. 2005 Mar 11;307(5715):1625-30</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15705806</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Ann N Y Acad Sci. 2005 Jun;1052:136-44</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16024756</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Pharmacol Exp Ther. 2006 Mar;316(3):1195-201</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16291875</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>IUBMB Life. 2005 Nov;57(11):711-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16511963</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Chem Biol. 2006 Apr;2(4):207-12</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16520733</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Neurosci. 2006 May 24;26(21):5649-55</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16723521</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Neurosci. 2006 Dec 13;26(50):13048-53</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17167094</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Neurosci Res. 2007 May 15;85(7):1478-88</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17387690</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>ACS Chem Biol. 2007 Aug 17;2(8):536-44</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17655271</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Eur J Pain. 2008 May;12(4):472-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17869144</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Neurosignals. 2008;16(2-3):140-53</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18253054</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Annu Rev Physiol. 2008;70:165-90</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18271749</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Curr Neuropharmacol. 2004 Oct;2(4):395-402</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18997874</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Neurosci Res. 2009 May 15;87(7):1610-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19125412</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Neuroendocrinol. 2009 Mar;21(4):263-70</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19187465</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Pain. 2009 May;10(5):509-16</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19231294</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Physiol Endocrinol Metab. 2009 Aug;297(2):E416-26</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19531642</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Mol Cell Endocrinol. 2009 Sep 24;308(1-2):17-25</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19549588</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Physiol. 2009 Nov 1;587(Pt 21):5019-23</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19687123</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Drug Alcohol Depend. 2010 Nov 1;112(1-2):90-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20634006</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Pain. 2010 Dec;151(3):806-15</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20926192</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Neurosci. 2011 Aug 17;31(33):11836-45</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21849544</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Endocrinology. 2012 Jul;153(7):2953-62</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22495674</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Biol Chem. 2012 Sep 28;287(40):33268-81</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22869379</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>ACS Chem Neurosci. 2013 Feb 20;4(2):214-24</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23421672</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Neuroscience. 2013;255:177-90</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24452062</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Neuroscience. 2014 May 16;267:122-34</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24613724</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Behav Pharmacol. 2014 Aug;25(4):267-76</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24978483</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Med Hypotheses. 2015 Feb;84(2):100-3</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25561322</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Neuroendocrinology. 2016;103(6):787-805</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26765570</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Womens Health (Larchmt). 2018 Aug;27(8):965-973</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">30129895</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Arch Androl. 1981 Nov;7(3):205-17</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">7305538</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Science. 1995 Nov 3;270(5237):792-4</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">7481766</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Arthritis Rheum. 1995 Jan;38(1):19-28</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">7818567</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>FASEB J. 1995 Mar;9(5):404-10</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">7896011</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>FEBS Lett. 1994 Jun 27;347(2-3):284-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8034019</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>FEBS Lett. 1994 Mar 14;341(1):33-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8137918</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Neuroreport. 1996 Sep 2;7(13):2092-4</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8930965</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Brain Res Mol Brain Res. 1997 Apr;45(1):117-26</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9105677</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Br J Pharmacol. 1998 Sep;125(2):373-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9786511</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Neurosci. 1999 Feb 15;19(4):1179-88</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9952396</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Mol Endocrinol. 1999 Feb;13(2):307-19</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9973260</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations>
<list>
<country>
<li>États-Unis</li>
</country>
<region>
<li>Tennessee</li>
</region>
</list>
<tree>
<country name="États-Unis">
<region name="Tennessee">
<name sortKey="Wright, Danyeal M" sort="Wright, Danyeal M" uniqKey="Wright D" first="Danyeal M" last="Wright">Danyeal M. Wright</name>
</region>
<name sortKey="Mokha, Sukhbir S" sort="Mokha, Sukhbir S" uniqKey="Mokha S" first="Sukhbir S" last="Mokha">Sukhbir S. Mokha</name>
<name sortKey="Nag, Subodh" sort="Nag, Subodh" uniqKey="Nag S" first="Subodh" last="Nag">Subodh Nag</name>
<name sortKey="Small, Keri M" sort="Small, Keri M" uniqKey="Small K" first="Keri M" last="Small">Keri M. Small</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/MersV1/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000684 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 000684 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    MersV1
   |flux=    PubMed
   |étape=   Checkpoint
   |type=    RBID
   |clé=     pubmed:31234278
   |texte=   Activation of Membrane Estrogen Receptors Attenuates NOP-Mediated Tactile Antihypersensitivity in a Rodent Model of Neuropathic Pain.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i   -Sk "pubmed:31234278" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd   \
       | NlmPubMed2Wicri -a MersV1 

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Mon Apr 20 23:26:43 2020. Site generation: Sat Mar 27 09:06:09 2021